Use access key #2 to skip to page content.
$39.58 3.08 (8.44%)
10/13/2008 4:03 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar clu2000 (92.49) Submitted: 10/26/06 2:38 PM : Outperform Start Price: $56.86 AZN Score: 5.00

earnings continue to rise, despite one drug not working

Report this Post Replies: 0 | Reply

Featured Broker Partners